$183 Million is the total value of Broadleaf Partners, LLC's 65 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ABBV | Abbvie Inc | $468,000 | +17.0% | 5,281 | 0.0% | 0.26% | +2.4% | |
ABT | Abbott Laboratories | $461,000 | +3.8% | 5,306 | 0.0% | 0.25% | -9.0% | |
BLL | Ball Corporation | $349,000 | -11.2% | 5,400 | 0.0% | 0.19% | -22.4% | |
IBB | iShares NASDAQ Biotechnology Eetf | $302,000 | +21.3% | 2,504 | 0.0% | 0.16% | +5.8% | |
SDY | Spdr S&P Dividend ETFetf | $263,000 | +4.8% | 2,448 | 0.0% | 0.14% | -8.3% | |
GLD | Spdr Gold Shares ETFetf | $262,000 | +2.7% | 1,836 | 0.0% | 0.14% | -10.1% | |
MCO | Moodys Corp | $254,000 | +16.0% | 1,070 | 0.0% | 0.14% | +1.5% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-01-31
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Microsoft Corp. | 27 | Q2 2024 | 7.5% |
Apple Inc. | 27 | Q2 2024 | 7.4% |
Alphabet Inc. Class C | 27 | Q2 2024 | 6.2% |
SCHWAB INTERNATIONAL EQUITY ET | 27 | Q2 2024 | 4.2% |
Mastercard Inc Class A | 27 | Q2 2024 | 3.8% |
CHARLES SCHWAB US MC ETF | 27 | Q2 2024 | 2.4% |
UNION PACIFIC CORP | 27 | Q2 2024 | 3.4% |
HOME DEPOT INC | 27 | Q2 2024 | 2.7% |
SCHWAB US DIVIDEND EQUITY ETF | 27 | Q2 2024 | 1.4% |
VANGUARD FTSE EMERGING MARKETS | 27 | Q2 2024 | 1.6% |
View Broadleaf Partners, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-08-12 |
N-PX | 2024-08-09 |
13F-HR | 2024-05-14 |
13F-HR | 2024-02-13 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-11 |
13F-HR | 2023-02-10 |
13F-HR | 2022-11-08 |
13F-HR | 2022-08-09 |
View Broadleaf Partners, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.